SROMPL Export Consulting

Your Import/Export Solution

UAE Healthcare Market Analysis, Regulatory and Competitive Landscape – GlobalData

Are you Looking For Import Export Consultant ?

Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Published: April 22, 2022 Report Code: GDHC0065CHR-ST
The UAE pharmaceutical market size was $3.5 billion in 2020. The market is expected to grow at a CAGR of more than 7% during the forecast period. The UAE medical devices market size was $2.4 billion in 2021. The market is expected to grow at a CAGR of more than 3% during 2022-2027. The UAE pharmaceutical industry has considerable development potential for international drugmakers, as the second-largest economy among Arab countries, after Saudi Arabia. The trend in market preferences toward generic drugs and other medical products may influence the future trajectory of the UAE pharmaceuticals sector, as enterprises increasingly attempt to produce generics to keep up with current market dynamics.
UAE Pharmaceuticals Market Outlook, 2020-2027 ($ Billion)
UAE pharmaceuticals market outlook


To know more about the UAE pharmaceutical market forecast, download a free report sample
UAE Medical Devices Market Outlook, 2021-2027 ($ Billion)
UAE medical devices market outlook

To know more about the UAE medical devices market forecast, download a free report sample
The UAE Healthcare market research report provides the market overview, segments, import and export partners, as well as companies associated with the UAE pharmaceutical market.
The report also provides the market details, types, and companies associated with the UAE medical devices market.
In order to meet the demands of the projected population rise, the Dubai Health Authority (DHA) planned to improve the absorptive capacity of clinical services by 2030. This includes increasing the number of beds, operating theatres, and critical care units. Rapid economic, social, and demographic reforms including government-led projects, elimination of several infectious illnesses, easy access to high-quality healthcare facilities, decreased maternal mortality rates, and evidence-based therapies have resulted in higher life expectancy and relative prosperity. In 2020, the UAE cabinet adopted the National Policy on Vaccinations which is intended to boost the country’s position as a domestic and global healthcare hub through an integrated and trustworthy healthcare system, as well as guaranteed access to high-quality vaccination services in compliance with international safety principles.
The top import partners of the UAE are the US, Germany, France, Switzerland, and Ireland. The US accounts for the highest percentage in the import business. The top export partners of the UAE are Kuwait, Iraq, Bahrain, Lebanon, and Jordan.
The key segments in the UAE pharmaceuticals market are generics, biologics, biosimilars, and over the counter (OTC).
Some of the key players in the UAE pharmaceuticals market are Johnson & Johnson (J&J), F. Hoffmann-La Roche Ltd. (Roche), Boehringer Ingelheim, Merck KGaA, and Gulf Pharmaceutical Industries-Julphar.
UAE Pharmaceuticals Market Analysis by Key Companies, 2020 (%)
UAE pharmaceuticals market, by key companies

To know more about key pharmaceutical companies, download a free report sample
The UAE is robust in healthcare infrastructure. As a result, the medical device industry has made considerable progress and expansion. Hospitals and clinics in the UAE have top-notch medical instruments and equipment frequently purchased from prominent US corporations. The UAE has taken advantage of its connections with renowned firms to gain modern medical technologies during the COVID-19 pandemic.
The key segments in the medical devices market in the UAE are hospital supplies, orthopedic devices, general surgery, cardiovascular devices, and neurology devices. Hospital supplies has the highest share among them in the market.
UAE Medical Devices Market Analysis by Segments
UAE medical devices market, by segments

To know more about segment insights into the UAE medical devices market, download a free report sample
Some of the major players in the medical devices market in the UAE are Abbott, B. Braun Melsungen AG (B. Braun), Zimmer Biomet Holdings Inc (Zimmer Biomet), Terumo, and Smith & Nephew.
UAE Medical Devices Market Analysis by Companies, 2020 (%)
UAE medical devices market, by key companies

To know more about medical device companies, download a free report sample
This report provides:

  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers.
  • Profiles and SWOT analyses of the major players in the pharmaceutical market: Johnson & Johnson, Roche, Boehringer Ingehlheim, Merck, and Julphar.
  • Profiles and SWOT analyses of the major players in the medical device market: Abbott, B Braun, Zimmer Biomet, Terumo, and Smith & Nephew.
  • An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices.
  • Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure, and healthcare expenditure.
  • An overview of the opportunities for and challenges to growth in the UAE’s healthcare market.

  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers.
  • Profiles and SWOT analyses of the major players in the pharmaceutical market: Johnson & Johnson, Roche, Boehringer Ingehlheim, Merck, and Julphar.
  • Profiles and SWOT analyses of the major players in the medical device market: Abbott, B Braun, Zimmer Biomet, Terumo, and Smith & Nephew.
  • An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices.
  • Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure, and healthcare expenditure.
  • An overview of the opportunities for and challenges to growth in the UAE’s healthcare market.
  • Reasons to Buy

    • Develop business strategies by understanding the trends shaping and driving the UAE healthcare market.
    • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the UAE healthcare market in the future.
    • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance.
    • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership.

  • Develop business strategies by understanding the trends shaping and driving the UAE healthcare market.
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the UAE healthcare market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership.
  • 1. Table of Contents

    1.1 List of Figures

    1.2 List of Tables

    2. Executive Summary

    2.1 Executive Summary

    2.2 Key Highlights: Facts about the UAE Healthcare Market

    2.3 Key Highlights: Healthcare Startups in UAE

    2.4 Key Events: UAE Healthcare Industry, 2015–21

    2.5 Key Events: UAE Pharmaceutical Market

    2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2020–22

    2.7 Key Events: Top Completed Deals by Value, 2020-22

    2.8 Country Profile, UAE, 2022

    3. Overview of the Pharmaceutical Market

    3.1 Pharmaceutical Market – Overview

    3.2 Pharmaceutical Market – Exports

    3.3 Pharmaceutical Market – Imports

    3.4 Pharmaceutical Market – Supply Channels, UAE

    3.5 Pharmaceutical Market – Market Segments

    3.6 Major Therapeutic Areas, UAE

    3.7 COVID-19 Epidemiology, UAE

    3.8 COVID-19 Impact and Developments, UAE

    3.9 COVID-19 Impact and Developments in the Healthcare Market, UAE

    3.10 COVID-19 Clinical Trials Landscape, UAE

    3.11 Pharmaceutical Market – Major Players

    4. Overview of Medical Devices Market

    4.1 Medical Device Market – Overview

    4.2 Medical Devices Market – Major Players

    5. Pharmaceutical and Medical Devices Market – Drivers and Barriers

    5.1 Drivers

    5.2 Barriers

    6. Deal Analysis

    6.1 Deal Analysis: Pharmaceutical Market, UAE, 2015–21

    6.2 Deal Analysis: Medical Device Market, UAE, 2015–21

    7. HealthTech Landscape

    7.1 HealthTech Landscape, UAE

    7.2 Digital Statistics, UAE

    7.3 Adoption of Technology in Healthcare, UAE

    7.4 HealthTech Deals Landscape, UAE

    7.5 Key HealthTech Deals, UAE

    7.6 Digital Regulations, UAE

    7.7 HealthTech Landscape: Benefits and Risks, UAE

    8. Market Access

    8.1 Overview of Healthcare System, UAE

    8.2 Overview of Insurance Providers, Public Insurance, UAE

    8.3 Overview of Insurance Providers, Private Insurance, UAE

    8.4 Reimbursement Process, UAE

    8.5 Out-of-Pocket Spending and Healthcare Price Index, UAE

    8.6 Pricing Policies, UAE

    8.7 Market Access: Key Events Timeline, UAE, 2010–21

    8.8 Regulatory Landscape, UAE

    8.8.1 Overview of Regulatory Agencies, UAE

    8.8.2 Marketing Authorization for Pharmaceutical Products, UAE

    8.8.3 Marketing Authorization for Generic Medicines, UAE

    8.8.4 Marketing Authorization for Biosimilars, UAE

    8.8.5 Marketing Authorization for Pharmaceutical Products Derived from Natural Sources, UAE

    8.8.6 Marketing Authorization for Medical Devices, UAE

    8.8.7 Pharmaceutical Establishment Regulations, UAE

    8.8.8 Pharmaceutical Export and Import Regulations, UAE

    8.8.9 Medical Device Import Regulations, UAE

    8.8.10 Intellectual Property Rights, Patent, UAE

    8.8.11 Intellectual Property Rights, Trademark, UAE

    8.8.12 Clinical Trial Regulation Process, UAE

    8.8.13 Pharmaceutical Clinical Trials Landscape, UAE

    8.8.14 Medical Device Clinical Trials Landscape, UAE

    8.8.15 Pharmaceutical and Medical Device Advertising Regulations, UAE

    8.8.16 Labeling and Packaging Regulations, UAE

    9. Country Healthcare Landscape

    9.1 UAE Healthcare Policy Highlights

    9.2 Healthcare Facilities, UAE

    9.3 Life Expectancy, UAE

    9.4 Immunization Rate, UAE

    9.5 Environmental Health, UAE

    9.6 Healthcare Personnel, UAE

    9.7 Disease Burden, UAE

    9.8 Healthcare Expenditure, UAE

    10 Trade Associations, UAE

    11 Trade Fairs, UAE

    12 Opportunities and Challenges

    13Appendix

    13.1 Research Methodology

    13.1.1 Coverage

    13.1.2 Secondary Research

    13.1.3 Forecasts

    13.2 Bibliography

    13.3 About GlobalData

    13.4 Contact Us

    13.5 Disclaimer

    Table 1: List of locally manufactured over-the-counter medicines, UAE, 2022

    Table 2: List of OTC-G medicines, UAE, 2022

    Table 3: List of OTC-P medicines, UAE, 2022

    Table 4: COVID-19 indicators (number), UAE and Global, 2022

    Table 5: Travel restrictions imposed during COVID-19, UAE, 2020–22

    Table 6: COVID-19 vaccine type and booster doses, UAE, 2022

    Table 7: Medical devices market, major segments ($M), UAE, 2021

    Table 8: Insurance Providers, UAE, 2021

    Table 9: Profit rates for drug pricing, UAE, 2021

    Table 10: Pharmaceutical pricing criteria, UAE, 2021

    Table 11: Pharmaceutical product service fees, UAE, 2022

    Table 12: Service fees for pharmaceutical products derived from natural sources , UAE, 2022

    Table 13: Medical device service fees, UAE, 2022

    Table 14: Pharmaceutical establishment service fees, UAE, 2022

    Table 15: Export service fees, UAE, 2022

    Table 16: Patent application fee, UAE, 2022

    Table 17: Advertisement service fees, UAE, 2019

    Table 18: Trade fairs, UAE, 2022

    Figure 1: Pharmaceutical market, revenue ($B), UAE, 2016–22

    Figure 2: Medical device market, revenue ($B), UAE, 2016–21

    Figure 3: Healthcare startups in UAE, 2022

    Figure 4: Country profile, UAE, 2022

    Figure 5: Pharmaceutical market, revenue ($B), UAE, 2016–21

    Figure 6: Pharmaceutical market, revenue forecast ($B), UAE, 2022–27

    Figure 7: Pharmaceutical exports ($M), UAE, 2014–20

    Figure 8: Top export partners, UAE, 2020

    Figure 9: Pharmaceutical imports ($B), UAE, 2014–20

    Figure 10: Top import partners, UAE, 2020

    Figure 11: Pharmaceutical distribution channels, UAE, 2021

    Figure 12: Tatmeen, a track-and-trace platform, UAE, 2021

    Figure 13: Major generic medicine manufacturers, UAE, 2021

    Figure 14: OTC medicines market, revenue ($M), UAE, 2014–21

    Figure 15: OTC medicines market, major distribution channels ($M), UAE, 2021

    Figure 16: OTC market by sub-categories of drugs, revenue ($M), UAE, 2021

    Figure 17: Major therapeutic areas, % (value), UAE, 2021

    Figure 18: Major therapeutic areas, % (volume), UAE, 2021

    Figure 19: COVID-19 (number of cases), UAE, 2020–22

    Figure 20: COVID-19 (number of deaths), UAE, 2020–22

    Figure 21: Stringency index, COVID-19, UAE, 2020–22

    Figure 22: Containment and health index, COVID-19, UAE, 2020–22

    Figure 23: COVID-19 Fiscal stimulus packages, UAE, 2020–21

    Figure 24: COVID-19 Vaccine doses administration, number of vaccine doses administered, UAE, 2022

    Figure 25: COVID-19 Vaccine booster doses administration, number of vaccine doses administered per 100 people, UAE, 2022

    Figure 26: Top COVID-19 markets by product categories (number of available marketed products), UAE, 2020–22

    Figure 27: Top COVID-19 products by equipment type (number of available marketed products), UAE, 2020–22

    Figure 28: Companies manufacturing COVID-19 NAATS and POC tests (number of available marketed products), UAE, 2020–22

    Figure 29: Top COVID-19 Nucleic acid amplification tests by equipment type (number of available marketed products), UAE, 2020–22

    Figure 30: COVID-19 clinical trial sponsors by trial count, UAE, 2020–22

    Figure 31: COVID-19 clinical trials count by phase, UAE, 2020–22

    Figure 32: COVID-19 clinical trials count by trial status, UAE, 2020–22

    Figure 33: Medical devices market, revenue ($B), UAE, 2016–21

    Figure 34: Medical devices market, revenue forecast ($B), UAE, 2022–27

    Figure 35: Medical devices market, major segments (%), UAE, 2021

    Figure 36: Hospital supplies market, revenue ($M), UAE, 2016–27

    Figure 37: Orthopedic devices market, revenue ($M), UAE, 2016–27

    Figure 38: General surgery market, revenue ($M), UAE, 2016–27

    Figure 39: Cardiovascular devices market, revenue ($M), UAE, 2016–27

    Figure 40: Neurology devices market, revenue ($M), UAE, 2016–27

    Figure 41: Diagnostics market, revenue ($M), UAE, 2016–21

    Figure 42: Diagnostics market, revenue forecast ($M), UAE, 2022–27

    Figure 43: Medical devices market, revenue ($B) of major companies, UAE, 2020

    Figure 44: Deal value and deal count, pharmaceutical market, UAE, 2015–21

    Figure 45: Deal value and deal count, quarterly, pharmaceutical market, UAE, 2015–21

    Figure 46: Deal value and deal count subtypes, pharmaceutical market, UAE, 2015–21

    Figure 47: Top therapy areas by deal value ($M), pharmaceutical market, UAE, 2015–21

    Figure 48: Top therapy areas by deal count, pharmaceutical market, UAE, 2015–21

    Figure 49: M&A deals bi-annually (by value and by number), pharmaceutical market, UAE, 2015–21

    Figure 50: Deal value and deal count, medical devices market, UAE, 2015–21

    Figure 51: Deal value and deal count, quarterly, medical devices market, UAE, 2015–21

    Figure 52: Deal value and deal count subtypes, medical devices market, UAE, 2015–21

    Figure 53: Top equipment sectors by deal value ($M), medical devices market, UAE, 2015–21

    Figure 54: Top equipment sectors by deal count, medical devices market, UAE, 2015–21

    Figure 55: Overview of DOH policy on digital health, UAE, 2020

    Figure 56: Deal value ($M) and deal count (number of deals), HealthTech, UAE, 2015–21

    Figure 57: Deal value ($M) and deal count (number of deals) by deal sub-category, HealthTech, UAE, 2015–21

    Figure 58: Overview of the priority areas of the DOH Policy on the Abu Dhabi Health Information Exchange, UAE, 2020

    Figure 59: Organizational structure of healthcare system, UAE, 2021

    Figure 60: Issue of a Health Card, UAE, 2021

    Figure 61: Drug formulary application requirements, UAE, 2021

    Figure 62: Pharmaceutical reimbursement process, UAE, 2021

    Figure 63: Out-of-pocket spending ($ per capita and % of health spending), UAE, 2014–21

    Figure 64: Annual inflation rate in health price index (% change accumulated in the year),UAE, 2015–21

    Figure 65: Distribution of out-of-pocket health expenditure (%), UAE, 2019

    Figure 66: Medicine pricing process, UAE, 2021

    Figure 67: Pharmaceutical product registration, UAE, 2022

    Figure 68: Biosimilar licensing procedure, UAE, 2019

    Figure 69: Requirements for registration of medicines derived from natural sources, UAE, 2022

    Figure 70: Required documents for registration of medical devices, UAE, 2022

    Figure 71: Medical device registration, UAE, 2022

    Figure 72: Requirements for pharmaceutical establishment registration, UAE, 2019

    Figure 73: Pharmaceutical establishment registration, UAE, 2019

    Figure 74: Export of medicines, UAE, 2019

    Figure 75: Required documents for import of medicines for personal use, UAE, 2022

    Figure 76: Procedure for obtaining an approval for import of medicines for personal use, UAE, 2022

    Figure 77: Required documents for import of medicines from a local agent, UAE, 2022

    Figure 78: Procedure for obtaining an approval for import of medicines from a local agent , UAE, 2022

    Figure 79: Documents required for the import of medical devices, UAE, 2022

    Figure 80: Procedure for obtaining an approval for import of medical devices, UAE, 2022

    Figure 81: Patent application process, UAE, 2022

    Figure 82: Trademark application process, UAE, 2022

    Figure 83: Regulatory process for interventional clinical trial approval, UAE, 2021

    Figure 84: Regulatory process for non-interventional clinical trial approval, UAE, 2021

    Figure 85: Pharmaceutical clinical trials count by trial status, UAE, 2020–22

    Figure 86: Pharmaceutical clinical trials count by phase, UAE, 2020–22

    Figure 87: Pharmaceutical clinical trials count by indication, UAE, 2020–22

    Figure 88: Top five pharmaceutical clinical trials sponsors by count, UAE, 2020–22

    Figure 89: Medical devices clinical trials count by trial status, UAE, 2020–22

    Figure 90: Medical devices clinical trials count by indication, UAE, 2020–22

    Figure 91: Medical devices clinical trials count by device category, UAE, 2020–22

    Figure 92: Top five medical devices clinical trials sponsors by count, UAE, 2020–22

    Figure 93: Advertisement service approval, UAE, 2019

    Figure 94: Packaging and labeling information, UAE, 2021

    Figure 95: Number of hospitals, UAE, 2014–21

    Figure 96: Number of public and private hospitals, UAE, 2014–21

    Figure 97: Number of hospital beds (per 10,000 population), UAE, 2014–21

    Figure 98: Number of CT scanners and MRI units, UAE, 2015–21

    Figure 99: Life expectancy at birth (years), UAE, 2014–21

    Figure 100: Immunizations below one year by type of vaccine, UAE, 2019

    Figure 101: Immunization rate (%), UAE, 2014–21

    Figure 102: PM2.5 (µg per m3), UAE, 2014–21

    Figure 103: CO2 emissions (million tons), UAE, 2014–21

    Figure 104: Physicians (per 10,000 population), UAE, 2014–21

    Figure 105: Dentists (per 10,000 population), UAE, 2014–21

    Figure 106: Pharmacists (per 10,000 population), UAE, 2014–21

    Figure 107: Nurses (per 10,000 population), UAE, 2014–21

    Figure 108: Major causes of mortality (per 100,000 population), UAE, 2019

    Figure 109: Major causes of male mortality (per 100,000 population), UAE, 2019

    Figure 110: Major causes of female mortality (per 100,000 population), UAE, 2019

    Figure 111: DALYs by major disease (per 100,000 population), UAE, 2019

    Figure 112: Healthcare expenditure as percentage of GDP (%), UAE, 2014–21

    Figure 113: Health expenditure share (% of total health spending), UAE, 2014–21

    The UAE pharmaceuticals market size was valued at $3.5 billion in 2020.
     
     
     
     
     

    The pharmaceuticals market in the UAE is expected to grow at a CAGR of more than 7% during the forecast period.

    The key segments in the pharmaceuticals market in the UAE are generics, biologics, biosimilars, and over the counter (OTC).

    The key import partners of the UAE are the US, Germany, France, Switzerland, and Ireland. The key export partners of the UAE are Kuwait, Iraq, Bahrain, Lebanon, and Jordan.

    Some of the key players in the UAE pharmaceuticals market are Johnson & Johnson (J&J), F. Hoffmann-La Roche Ltd. (Roche), Boehringer Ingelheim, Merck KGaA, and Gulf Pharmaceutical Industries-Julphar.

    The UAE medical devices market size was valued at $2.4 billion in 2021.
     
     
     
     

    The UAE medical devices market is expected to grow at a CAGR of more than 3% from 2022-2027.

    The key segments in the medical devices market of UAE are hospital supplies, orthopedic devices, general surgery, cardiovascular devices, and neurology devices.

    Some of the major players in the medical devices market of the UAE are Abbott, B. Braun Melsungen AG (B. Braun), Zimmer Biomet Holdings Inc (Zimmer Biomet), Terumo, and Smith & Nephew.
    Can be used by individual purchaser only
    Can be shared by unlimited users within one corporate location e.g. a regional office
    Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
    [email protected]
    Tel +44 20 7947 2745

    Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
    United Arab Emirates (UAE) Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:
    Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

    “The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.
    GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

    “COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

    Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

    Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

    Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.
    I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.
    I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

    “I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.
    Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

    GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.
    I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.
    One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.
    Every Company Report we produce is powered by the GlobalData Intelligence Center.
    Subscribing to our intelligence platform means you can monitor developments at United Arab Emirates (UAE) Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape in real time.

    source

    x